CORT

Corcept Therapeutics Inc.
$70.44 +1.37%

Recent alerts on CORT

All signals →
Insider trade Sale by Lyon Joseph Douglas (See Remarks)
3d ago
Insider trade Sale by Maduck Sean (See Remarks)
3d ago
News Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week
14d ago
News Corcept Moves 6.5% Higher: Will This Strength Last?
14d ago
News Corcept (CORT) Shares Rise 20% in Three Months: Here's Why
14d ago
News Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
14d ago
News Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
14d ago
News Why Corcept Therapeutics Plummeted by 50% Today
14d ago
News Corcept Therapeutics climbs on UBS upgrade
20d ago
Insider trade Sale by William Guyer (Chief Development Officer)
25d ago
Insider trade Sale by BELANOFF JOSEPH K (Chief Executive Officer)
27d ago
News Corcept raises 2026 revenue guidance to $950M-$1.05B as it targets $2B Cushing’s sales and $1B+ Lifyorli by decade-end
32d ago
Insider trade Sale by William Guyer (Chief Development Officer)
54d ago
SEC filing CORT Announces FDA Approval of Lifyorli Plus Nab-Paclitaxel for Platinum-Resistant Ovarian Cancer, 35% OS Reduction, 16.0-Month Median Survival
69d ago
News Corcept granted FDA nod for cancer therapy
69d ago
Insider trade Sale by William Guyer (Chief Development Officer)
69d ago
News Corcept rises after insider buy worth over $3M
74d ago
Insider trade Purchase by BAKER G LEONARD JR
74d ago
Insider trade Sale by William Guyer (Chief Development Officer)
87d ago
News INVESTOR DEADLINE: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company Announcement - FT.com
99d ago
Insider trade Sale by William Guyer (Chief Development Officer)
104d ago
News Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman
137d ago
News Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts?
138d ago
News CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
138d ago
News Corcept Insider Transaction Explained After Shares Tumble 50% in One Day
141d ago

Get push alerts for CORT

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS